Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from in-PharmaTechnologis

02:42 EDT 23rd June 2018 | BioPortfolio

Here are the most relevant search results for "in-PharmaTechnologis" found in our extensive news archives from over 250 global news sources.

More Information about in-PharmaTechnologis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about in-PharmaTechnologis for you to read. Along with our medical data and news we also list in-PharmaTechnologis Clinical Trials, which are updated daily. BioPortfolio also has a large database of in-PharmaTechnologis Companies for you to search.

Showing News Articles 1–25 of 383 from in-PharmaTechnologis

Thursday 21st June 2018

Indivior seeks injunction to block Dr. Reddy’s generic launch in US

Indivior has requested a temporary restraining order against Dr. Reddyâs Laboratories to prevent further sales of its generic buprenorphine and naloxone sublingual film product in the US.

Orion signs VagiVital commercial supply deal, oversees tech transfer

Orion Contract Manufacturing will make, package, and supply Peptonic Medicalâs over-the-counter VagiVital product, which is set to launch later this year.

Patented cannabinoid method produces ‘nearly pure molecules’ says Axim Biotech

Axim Biotechnologiesâ âextremely efficientâ cannabinoid molecule extraction and purification method has received a US patent.

Wednesday 20th June 2018

Spanish authorities make illicit meds bust, dismantle three labs

The Spanish National Police has uncovered three secret laboratories and seized âthousands of cartonsâ of counterfeit medicines, says Europol.

Adents launches NovaTrack: 'Blockchain will help secure certain parts of track and trace'

Adents has combined artificial intelligence and Microsoft Blockchain-based technology to help secure and analyse transactions across the supply chain.

Sterling Pharma: Highly potent API demand driving expansion as it looks to Asia

A growing client base in the US and healthy demand for highly potent active pharmaceutical ingredients (HPAPIs) are driving expansion at the UK-based CDMO Sterling Pharma Solutions.

Tuesday 19th June 2018

Mylan awaits US FDA rejection for GSK generic

Mylan says âminor deficienciesâ in its abbreviated new drug application for its proposed generic version of GSKâs Advair Diskus have prompted the US FDA to issue a complete response letter.

US FDA rejects Valeant’s Duobrii for plaque psoriasis

The US FDA has rejected Valeant Pharmaceutical Internationalâs investigational topical treatment for plaque psoriasis, Duobrii.

DSP expanding statins portfolio with EU launch of generic Atorvastatin

DSP has released its generic Atorvastatin drug product within the EU with additional markets to be added later this year the firm looks to become a full-service generics company.

Monday 18th June 2018

Recipharm buys Sanofi CMO site in UK, signs long-term supply deal

Sanofi is handing off its Holmes Chapel facility and all existing contract manufacturing agreements to CDMO Recipharm.

US FDA warns Taiwan Biotech for ‘dubious’ reports at manufacturing site

A lack of âbasic documentationâ and âdubiousâ environmental control system reports at Taiwan Biotechâs manufacturing plant were cited in the US FDA warning letter.

Thursday 14th June 2018

Purogenix lays off 90% of workforce, seeks buyers

UK antibiotics maker Purogenix Ltd. has dismissed the majority of its employees and appointed two KPMG insolvency practitioners to manage its assets.

Flex Pharma to cut two trials, reduce headcount and explore merger options

Oral tolerability concerns have prompted the US biotech to close Ph II clinical trial investigations of FLX-787 in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT).

WuXi STA: China approves first CMO-made new drug

The first candidate made in accordance with Chinaâs Marketing Authorisation Holder pilot programme has received new drug application approval.

Wednesday 13th June 2018

Alcami supporting commercial supply of Flexion’s first FDA-approved product

Alcami began work on Flexion Therapeutics's ZILRETTA in the fall of 2014 and today announced that it will further support commercial supply of the product, which is approved for the treatment of OA-related knee pain.

Serialisation legislation could improve recall process for drugmakers, says exec

Impending EU serialisation regulations could enhance drug recall procedures for pharmaceutical companies, says executive.

Cambrex expands in Italy and Sweden: New hires, labs to be ready in 2019

Cambrexâs news that it will be constructing a research and development laboratory at its Italy-based site follows on the heels of its recently announced plans to begin a $5m expansion in Sweden.

Tuesday 12th June 2018

Sanofi to develop mRNA vaccines using ex-Shire platform

Sanofi Pasteur has teamed with Translate Bio to develop mRNA vaccines for infectious diseases, using a platform developed by subsidiaries of Shire plc.

FDA targets 20% efficiency gain from rejig of drug review office

The US Food and Drug Administration (FDA) is planning to reorganize its drug review office to make it 20% more efficient.

Monday 11th June 2018

Smallpox treatment nears FDA approval after years of development, collaboration

SIGA is slated to receive FDA approval for the worldâs first antiviral drug to treat smallpox â a milestone not reached in isolation, but in collaboration with several CROs, government agencies, and others.

Virpax targets opioid dependence with painkiller gel

Virpax Pharmaceuticals is developing a long-acting analgesic gel it says could reduce reliance on opioid pain management.

Friday 8th June 2018

Blockchain the perfect fit for digital supply chain? Industry not convinced

Blockchain is gaining momentum in the pharmaceutical industry, but consultant Pasi Kemppainen says he would be âcautiousâ to implement the technology across the entire digital supply chain.

Thursday 7th June 2018

Emergent initiates $50m expansion, expects to hire 60

Emergent BioSolutions has initiated a $50m multi-year expansion at the companyâs Baltimore, MD-based fill/finish facility.

UK initiative targets rapid production of thermally-stable vaccines

The Centre for Process Innovation (CPI) has confirmed its role in a UK initiative to accelerate vaccine production and eliminate the need for cold-chain shipping.

Australian API and generics maker hit with US FDA warning letter

Analytical testing concerns and âinadequateâ investigations into failed results were among the GMP deviations observed by the US FDA at IDT Australia Limitedâs facility.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks